2m 2m 2m 2m 2m 2m 2m
SCYNEXIS (SCYX)
NASDAQ
$4.89+$0.05 (+1.03%)
Price as of Aug 03, 2026 3:16 PM EDT- $48.1MMarket Cap
- -11.17%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
SCYNEXIS (SCYX)
$4.89+$0.05 (+1.03%)
SCYX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.84 | ||
Change | +$1.11 (+29.76%) | ||
Open | $3.60 | ||
High | $4.95 | ||
Low | $3.60 | ||
Previous Close | $3.73 | ||
Volume | 3,184,532 | ||
30-Day Average Volume | 222,070 | ||
1-Week Change | 29.76% | ||
1-Month Change | 18.92% | ||
1-Year Change | -11.17% | ||
3-Year Change | -79.49% | ||
5-Year Change | -91.32% | ||
Fundamentals | |||
Shares Outstanding | 9.9M | ||
Total Assets | $77.6M | ||
Market Cap | $48.1M | ||
Enterprise Value | $11.4M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$21.3M | ||
Free Cash Flow | -$16.1M | ||
EBIT | -$21.3M | ||
EBITDA | -$21.3M | ||
Net Working Capital | $46.8M | ||
EPS | -$3.36 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 8 | ||
Last Split Date | 06/01/2026 | ||
Earnings & Revenue